Home » News » Contract research organization Redbud raises $10 million in series A funding

Contract research organization Redbud raises $10 million in series A funding

by Babu Patil
Redbud funding

Redbud Medicine, a contract research organization (CRO), raised $10 million in series A funding.  

Investors include MING Bioventures Capital, Delian Capital, and the existing Angel round investor Hongfeng Capital. Legend Star led the Series pre-A round fundraising less than a year ago.

Redbud said that the new financing enables the company to streamline the execution of clinical trials from protocol design, CRF creation, and ongoing medical review through the final CSR. 

The company added that the funding would also support the planned growth and lay a solid foundation for global expansion in the near future.

Redbud Medicine is a next-generation clinical contract research organization focusing on science-based clinical development services. The company offers full-service development from bench to bedside, intending to reduce traditional clinical study timelines, improving overall quality and value-driven cost containment. Redbud’s global team of experts has extensive experience in a broad range of therapeutic areas and international clinical development. They work with sponsors to provide several bespoke options, including digital solutions and training for companies new to the drug development space. ...

Related Posts